Compare Abbott Laboratories (ABT) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Illinois Tool Works Inc. — how do they compare? Abbott Laboratories trades at $95.76 (market cap $166.94B), while Illinois Tool Works Inc. trades at $265.4 (market cap $77.99B). The key difference: Abbott Laboratories is far larger — about 2.1× Illinois Tool Works Inc.'s market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | ITW | |
|---|---|---|
Market Cap | $166.94B | $77.99B |
Sector | Health | Industrials |
52-Week High | $136.62 | $299.60 |
52-Week Low | $82.57 | $241.07 |
Enterprise Value | $193.69B | $86.31B |
Dividend Yield | 2.63% | 2.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
ITW trades at $271.09, down 0.61% on the day, with a bullish technical signal from moving averages and ADX indicators. The company maintains strong profitability with a 19.32% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights product upgrades from its Miller Electric division and a declared quarterly dividend of $1.61.
Outlook remains positive with raised 2026 EPS guidance, though valuation ratios like P/E of 25.47 suggest premium pricing. Risks include high debt levels and sensitivity to industrial demand cycles. Analyst consensus price target of $284.50 implies modest upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
